Industry News


News from the global pharmaceuticals industry about head lice treatments and corporate developments, including takeovers and mergers.

22.01.16 | Safety of Oral Ivermectin in Children

New commentary warns of the risks of excessive use of ivermectin for unauthorized groups.

14.09.15 | Xeglyze submitted for FDA approval, commercialisation deal announced

Hatchtech is submitting its Xeglyze lice treatment to the FDA for approval and has signed a commercialisation agreement with Dr. Reddy’s.

08.09.15 | Updated Pediculosis Pipeline insight report

DelveInsight have released an updated report covering the state of the pediculosis treatment pipeline.

28.08.15 | Eden Research license deal with TerpeneTech

Eden Research PLC has agreed a licensing deal with TerpeneTech Ltd granting exclusive use of its encapsulation technologies and other intellectual property for head lice treatments.

16.07.15 | Tyratech update: revenue and funding

Tyratech have announced increased revenues for 2014, and are focussing more of their funding on Vamousse.

15.06.15 | Lice Treatment Patent Infringement Complaint Filed

Larada Sciences Inc., a Utah-based head lice treatment company, have filed a complaint alleging patent infringement by Nitless Noggins, a California-based lice treatment company.

The patents concern methods for lice eradication via localised heat treatment, and are held by the University of Utah Research Federation, who have licensed them to Larada Sciences.

Larada Sciences developed AirAllé, a device for treating lice infection via heat treatment, which received FDA clearance in prior to its release with AirAllé branding in 2013.

09.06.15 | Lice Seminar

The Second European Liceworld Seminar, which will take place in Copenhagen, Denmark, is on Thursday and Friday 10 – 11 September 2015. It will bring together international head lice experts and a broad variety of professionals for whom head lice play an important role in their working lives.

10.04.15 | Further Vamousse distribution agreements

Tyratech, Inc. has recently announced two further US distribution agreements for Vamousse, its lice treatment product.

10.04.15 | Expansion plans for Australian lice companies

Hatchtech recently announced plans to commercialise its Xeglyze lice treatment product, while Ego Pharmaceuticals expand their international distribution network.

18.03.15 | Head lice treatment company financial updates

Several head lice companies have recently released financial updates related to their head lice treatments.

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 — all rights reserved